FDA Inspection 1099291 — Natco Pharma Ltd. - Chemical Division
The FDA completed an inspection of Natco Pharma Ltd. - Chemical Division on August 9, 2019 in Rangareddy District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 9, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rangareddy District (India)